Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Xortx Therapeutics Inc (XRTX)

Xortx Therapeutics Inc (XRTX)
1.0300 x 9 1.0700 x 1
Post-market by (Cboe BZX)
1.0500 +0.1800 (+20.69%) 04/22/25 [NASDAQ]
1.0300 x 9 1.0700 x 1
Post-market 1.0000 -0.0500 (-4.76%) 16:52 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.9000
Day High
1.1300
Open 0.9000
Previous Close 0.8700 0.8700
Volume 374,068 374,068
Avg Vol 32,653 32,653
Stochastic %K 58.98% 58.98%
Weighted Alpha -69.03 -69.03
5-Day Change +0.1200 (+12.90%) +0.1200 (+12.90%)
52-Week Range 0.8020 - 3.2400 0.8020 - 3.2400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,296
  • Shares Outstanding, K 3,788
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,310 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.08

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8020 +30.92%
on 04/09/25
Period Open: 1.0300
1.1300 -7.08%
on 04/22/25
+0.0200 (+1.94%)
since 03/21/25
3-Month
0.8020 +30.92%
on 04/09/25
Period Open: 0.9716
1.2500 -16.00%
on 02/27/25
+0.0784 (+8.07%)
since 01/22/25
52-Week
0.8020 +30.92%
on 04/09/25
Period Open: 3.0000
3.2400 -67.59%
on 04/29/24
-1.9500 (-65.00%)
since 04/22/24

Most Recent Stories

More News
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Announces Update for Discussion with the FDA

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Commences Gout Program NDA Discussions with the FDA

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX to Present at Microcap Conference

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Announces Change of Auditor

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Adds Late Stage Gout Program to Pipeline

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Strengthens Executive Team

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Announces Presentation at the Rare and Genetic Disease Summit

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XRTX.VN : 1.440 (+14.29%)
XRTX : 1.0500 (+20.69%)

Business Summary

XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta.

See More

Key Turning Points

3rd Resistance Point 1.0000
2nd Resistance Point 0.9740
1st Resistance Point 0.9220
Last Price 1.0500
1st Support Level 0.8440
2nd Support Level 0.8180
3rd Support Level 0.7660

See More

52-Week High 3.2400
Fibonacci 61.8% 2.3087
Fibonacci 50% 2.0210
Fibonacci 38.2% 1.7333
Last Price 1.0500
52-Week Low 0.8020

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro